HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,732 | -12.4% | 19,158 | -1.3% | 0.00% | – |
| Q2 2023 | $22,523 | -28.9% | 19,417 | -7.5% | 0.00% | – |
| Q1 2023 | $31,690 | -41.9% | 20,988 | -2.8% | 0.00% | – |
| Q4 2022 | $54,500 | -35.9% | 21,588 | +6.6% | 0.00% | – |
| Q3 2022 | $85,000 | +46.6% | 20,247 | -3.6% | 0.00% | – |
| Q2 2022 | $58,000 | -49.6% | 21,002 | +4.2% | 0.00% | – |
| Q1 2022 | $115,000 | -39.2% | 20,155 | -3.1% | 0.00% | – |
| Q4 2021 | $189,000 | -58.6% | 20,807 | -51.0% | 0.00% | -100.0% |
| Q3 2021 | $456,000 | -30.1% | 42,491 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +27.1% | 41,943 | +32.6% | 0.00% | 0.0% |
| Q1 2021 | $513,000 | +130.0% | 31,635 | +198.6% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | +77.0% | 10,596 | +24.7% | 0.00% | – |
| Q3 2020 | $126,000 | -1.6% | 8,495 | -2.6% | 0.00% | – |
| Q2 2020 | $128,000 | +456.5% | 8,718 | +343.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 1,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |